Benign and malignant hepatocellular lesions in patients with vascular liver disease.
作者信息
Vilgrain Valérie, Rautou Pierre-Emmanuel, Paradis Valérie, Ronot Maxime
机构信息
Department of Radiology Assistance-Publique Hôpitaux de Paris Hôpital Beaujon Clichy France.
Université Paris Diderot, Sorbonne Paris Cité, INSERM Centre de recherche Biomédicale Bichat Beaujon CRB3 U773 75018 Paris France.
出版信息
Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):122-125. doi: 10.1002/cld.338. eCollection 2014 Jun.
Abstract
摘要
相似文献
1
Benign and malignant hepatocellular lesions in patients with vascular liver disease.
Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):122-125. doi: 10.1002/cld.338. eCollection 2014 Jun.
2
Hepatocellular carcinoma: stiffness value and ratio to discriminate malignant from benign focal liver lesions.
Radiology. 2015 Jun;275(3):880-8. doi: 10.1148/radiol.14131164. Epub 2015 Jan 28.
3
Human liver tumors in relation to steroidal usage.
Environ Health Perspect. 1983 Apr;50:201-8. doi: 10.1289/ehp.8350201.
4
[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7.
5
Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
Am J Surg Pathol. 2009 Jun;33(6):874-85. doi: 10.1097/PAS.0b013e318194b3ea.
6
Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
J Clin Ultrasound. 2010 Jan;38(1):1-9. doi: 10.1002/jcu.20626.
7
Benign and malignant hepatocellular lesions in patients with vascular liver diseases.
Abdom Radiol (NY). 2018 Aug;43(8):1968-1977. doi: 10.1007/s00261-018-1502-7.
8
Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions.
Eur Radiol. 2016 Feb;26(2):398-406. doi: 10.1007/s00330-015-3835-8. Epub 2015 Jun 2.
9
Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
Cancer. 2000 Oct 25;90(5):273-8.
10
Peripheral endothelial cells are not reliable in differentiating primary benign and malignant hepatocellular lesions in fine needle aspirates of the liver.
Cytopathology. 2002 Jun;13(3):145-51. doi: 10.1046/j.1365-2303.2002.00406.x.
引用本文的文献
1
Role of Vascular Liver Diseases in Hepatocellular Carcinoma Development.
Cancers (Basel). 2025 Jun 20;17(13):2060. doi: 10.3390/cancers17132060.
2
Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.
Korean J Radiol. 2016 Jan-Feb;17(1):7-24. doi: 10.3348/kjr.2016.17.1.7. Epub 2016 Jan 6.
本文引用的文献
1
Congenital portosystemic shunts associated with liver tumours.
Clin Radiol. 2013 Jul;68(7):e362-9. doi: 10.1016/j.crad.2013.01.024. Epub 2013 Mar 26.
2
Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings.
Korean J Hepatol. 2011 Dec;17(4):313-8. doi: 10.3350/kjhep.2011.17.4.313.
3
Congenital extrahepatic portosystemic shunts (Abernethy malformation): a histopathologic evaluation.
Am J Surg Pathol. 2011 Sep;35(9):1381-90. doi: 10.1097/PAS.0b013e3182230ce4.
4
Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history.
Eur Radiol. 2011 Oct;21(10):2074-82. doi: 10.1007/s00330-011-2161-z. Epub 2011 Jun 28.
5
Complications of congenital portosystemic shunts in children: therapeutic options and outcomes.
J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):322-30. doi: 10.1097/MPG.0b013e3181d9cb92.
6
Focal nodular hyperplasia of the liver following hematopoietic SCT.
Bone Marrow Transplant. 2009 Jan;43(2):127-32. doi: 10.1038/bmt.2008.304. Epub 2008 Sep 22.
7
Review article: the hepatic manifestations of hereditary haemorrhagic telangiectasia.
Aliment Pharmacol Ther. 2008 Sep 1;28(5):523-33. doi: 10.1111/j.1365-2036.2008.03775.x. Epub 2008 Jun 20.
8
Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
Gut. 2008 Jun;57(6):828-35. doi: 10.1136/gut.2007.139477. Epub 2008 Jan 24.
9
[Focal nodular hyperplasia involving portal cavernoma].
Arch Pediatr. 2007 Nov;14(11):1315-7. doi: 10.1016/j.arcped.2007.07.009. Epub 2007 Oct 24.
10
High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia.
Ultrasound Med Biol. 2004 Sep;30(9):1089-97. doi: 10.1016/j.ultrasmedbio.2004.08.004.
Zotero 插件